Pittsburgh, PA – November 2, 2020: 3 Rivers Capital, LLC (“3RC”) is pleased to announce its new investment in R3 Wound Care and Hyperbarics (“R3”). R3 is a leading provider of high-quality, outpatient wound care clinics and hyperbaric oxygen therapy (“HBOT”) centers based in the Dallas/Ft. Worth, TX metropolitan area. R3 specializes in treating diabetic ulcers, arterial insufficiency wounds, radiation wounds, and non-diabetic surgical wounds. In addition to its three wound care clinics in Dallas/Ft. Worth, R3 also serves patients with a facility in the San Antonio region.

“The acquisition of R3 continues to broaden our strategy in the healthcare services space,” said Rob Carskadden, partner at 3RC. “We are proud to partner with the dedicated and experienced management team at R3, led by their CEO Bob Childs. R3’s commitment to patient health is demonstrated daily by delivering outstanding personalized care in a compassionate, safe, and effective manner.”

“The opportunity to partner with 3RC is a tremendous honor and great opportunity for our patients and the excellent staff at R3 Wound Care & Hyperbarics,” said Bob Childs, CEO of R3. My vision when I started R3 was to expand our footprint throughout the state of Texas and the neighboring states. Through our partnership with 3RC, we look forward to fulfilling this vision. Our focus will always be to treat and heal any patient who struggles with a wound, no matter how big or small.

Metz Lewis Brodman Must O’Keefe LLC served as lead legal counsel to 3 Rivers Capital.

3 Rivers Capital Completes Sale of Deep Well Services

About 3 Rivers Capital
3 Rivers Capital is a private equity firm focused on control acquisitions of small businesses with EBITDA between $4-10M.
Since its founding in 2005, 3 Rivers has built expertise in acquiring family and entrepreneur-owned businesses that present a clear and compelling opportunity to create significant value. 3 Rivers Capital adds value through active ownership and supportive partnerships with highly motivated management teams.